Picture of HealthEquity logo

HQY — HealthEquity News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge CapHigh Flyer

HSA administrator HealthEquity's Q3 revenue just beats estimates on asset growth

Overview

HealthEquity Q3 revenue rises 7% yr/yr, slightly beating analyst expectations

Adjusted EPS for Q3 beats consensus, while net income misses estimates

Company returned $93.7 mln to shareholders via stock repurchases

Outlook

Company expects fiscal year revenue between $1.302 bln and $1.312 bln

HealthEquity projects net income of $197 mln to $205 mln for fiscal year

Company forecasts Adjusted EBITDA of $555 mln to $565 mln for fiscal year

Result Drivers

HSA ASSETS GROWTH - Total HSA assets grew 15% to $34.4 bln, contributing to revenue increase

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueSlight Beat*$322.16 mln$321.03 mln (14 Analysts)
Q3 Adjusted EPSBeat$1.01$0.93 (13 Analysts)
Q3 Net IncomeMiss$51.69 mln$82.04 mln (11 Analysts)
Q3 Adjusted EBITDABeat$141.80 mln$132.78 mln (14 Analysts)
Q3 Pretax ProfitMiss$67.53 mln$110.42 mln (8 Analysts)
Q3 Gross Profit$228.06 mln
Q3 Operating Expenses$149.37 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers. Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell" The average consensus recommendation for the software peer group is "buy" Wall Street's median 12-month price target for Healthequity Inc is $122.50, about 23.9% above its December 2 closing price of $98.88 The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 22 three months ago Press Release: ID:nGNX8Bvs76 For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on HealthEquity

See all news